Patents by Inventor Laura Barreyro De Pujato

Laura Barreyro De Pujato has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Peptides for blocking IL1RAP protein-protein interaction and uses thereof for treatment of disease
    Patent number: 11137397
    Abstract: Methods and agents are provided for inhibiting interleukin 1 receptor accessory protein (IL1RAP) protein-protein interaction to treat a broad spectrum of diseases and conditions.
    Type: Grant
    Filed: November 23, 2015
    Date of Patent: October 5, 2021
    Assignee: Albert Einstein College of Medicine
    Inventors: Ulrich Steidl, Laura Barreyro De Pujato, Mario Pujato
  • PEPTIDES FOR BLOCKING IL1RAP PROTEIN-PROTEIN INTERACTION AND USES THEREOF FOR TREATMENT OF DISEASE
    Publication number: 20180275123
    Abstract: Methods and agents are provided for inhibiting interleukin 1 receptor accessory protein (IL1RAP) protein-protein interaction to treat a broad spectrum of diseases and conditions.
    Type: Application
    Filed: November 23, 2015
    Publication date: September 27, 2018
    Applicant: Albert Einstein College of Medicine, Inc
    Inventors: Ulrich Steidl, Laura Barreyro De Pujato, Mario Pujato
  • Treatment of acute myeloid leukemia and myelodysplastic syndromes
    Patent number: 9873918
    Abstract: Methods are disclosed for diagnosis, prognosis and therapy of acute myeloid leukemia and myelodysplastic syndromes using interleukin 1 receptor accessory protein and other targets.
    Type: Grant
    Filed: August 9, 2012
    Date of Patent: January 23, 2018
    Assignee: Albert Einstein College of Medicine, Inc.
    Inventors: Ulrich G. Steidl, Laura Barreyro De Pujato, Britta Will, Amit Verma
  • TARGETS FOR DIAGNOSIS, PROGNOSIS AND THERAPY OF ACUTE MYELOID LEUKEMIA AND MYELODYSPLASTIC SYNDROMES
    Publication number: 20150147271
    Abstract: Methods are disclosed for diagnosis, prognosis and therapy of acute myeloid leukemia and myelodysplastic syndromes using interleukin 1 receptor accessory protein and other targets.
    Type: Application
    Filed: August 9, 2012
    Publication date: May 28, 2015
    Applicant: Albert Einstein College of Medicine of Yeshiva University
    Inventors: Ulrich G. Steidl, Laura Barreyro De Pujato, Britta Will